UOC
AMRI

UBS O'Connor’s Albany Molecular Research Inc AMRI Stock Holding History

UBS O'Connor’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-10,000
Closed -$217K – 507
2017
Q2 		$217K Buy
+10,000
New +$181K ﹤0.01% 359

Other funds holding AMRI

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

UBS O'Connor's AMRI Position: Q3 2017 in Review

UBS O'Connor sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 10,000 shares — an estimated $217K sold.

UBS O'Connor first reported a position in AMRI in Q2 2017 and held it in 1 quarter. The position peaked at $217K in Q2 2017. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

  • UBS O'Connor reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
  • UBS O'Connor sold 10,000 Albany Molecular Research Inc shares in Q3 2017, an estimated $217K.
  • UBS O'Connor first reported a position in Albany Molecular Research Inc in Q2 2017 and held it in 1 quarter.
  • UBS O'Connor's Albany Molecular Research Inc position peaked at $217K in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on UBS O'Connor's 13F filing for Q3 2017, filed 14 Nov 2017.